Michelle Balmelli-Bice

Michelle Balmelli-Bice is an accomplished professional with extensive experience in national accounts and market access within the pharmaceuticals industry. Currently serving as Director of National Accounts for Bristol Myers Squibb since March 2024 and also for Karuna Therapeutics, Balmelli-Bice has held several key positions including Director of National Accounts at Albireo Pharma, Zogenix, and Provention Bio. In addition, a significant involvement with the AMCP includes roles as Board Advisor, National AMCP Membership Committee member, founding board member of the NW AMCP Affiliate, and Secretary/Treasurer for the affiliate. Balmelli-Bice's career also includes over 16 years at Gilead Sciences in various national accounts roles, as well as positions at Johnson & Johnson and Abbott. Educational qualifications include a BA in Business Administration & Marketing from Seattle University and executive management training from the Northwestern University Kellogg School of Management.